Table 2.

Treatment and outcome.

Treatment and Results, n = 290	Number of Patients (%)
Treatment
RT	66 (22.7)
RTCT	224 (77.2)
Residual disease
All	45 (15.6)
Primary site	26 (9)
Lymph nodes	11 (3.8)
Both	8 (2.8)
Primary site	Primary site residual disease, n = 34 (% of all patients, % of all patients in corresponding primary site)
Oropharynx	15 (5.2, 11.4)
Oral cavity	11 (3.8, 39.3)
Larynx	6 (2.1, 7.3)
Hypopharynx	1 (0.3, 3.1)
Nasopharynx	1 (0.3, 5.9)